Prestige Consumer Healthcare
251 hedge funds and large institutions have $2B invested in Prestige Consumer Healthcare in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 78 increasing their positions, 88 reducing their positions, and 30 closing their positions.
2,097% more call options, than puts
Call options by funds: $1.45M | Put options by funds: $66K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
70% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 30
7% more funds holding
Funds holding: 234 → 251 (+17)
11% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 88
12.17% less ownership
Funds ownership: 120.73% → 108.56% (-12%)
18% less capital invested
Capital invested by funds: $2.46B → $2B (-$454M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$8.31M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.13M |
| 3 |
NIPH
NN Investment Partners Holdings
The Hague,
Netherlands
|
+$6.18M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$4.87M |
| 5 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$4.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$75.3M |
| 2 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$59.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$28M |
| 4 |
Goldman Sachs
New York
|
-$18.6M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12.7M |
PBH Hedge Fund Activity: Q1 2020 in Review
251 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q1 2020, worth a combined $2B — down 18% from $2.46B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new PBH positions and 30 closed out — a net gain of 21 holders — while 78 added to existing stakes and 88 trimmed.
The largest buyer was Nuveen, adding an estimated $8.31M. The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $75.3M sold.
- 251 institutional investors held Prestige Consumer Healthcare (PBH) as of Q1 2020, up from 234 in Q4 2019.
- Funds reported $2B of Prestige Consumer Healthcare stock for Q1 2020, down 18% quarter-over-quarter.
- 51 funds opened new Prestige Consumer Healthcare positions in Q1 2020 and 30 closed out, a net change of +21 holders.
- The largest Prestige Consumer Healthcare buyer in Q1 2020 was Nuveen, an estimated $8.31M added.
- The largest Prestige Consumer Healthcare seller in Q1 2020 was ArrowMark Colorado Holdings, an estimated $75.3M sold.
Based on aggregated 13F filings for Q1 2020.